Torrent Pharmaceuticals (TORNTPHARM) — Financial Results

Torrent Pharmaceuticals reported FY25 revenue of ₹9,682 crores, up 7% YoY, with net profit of ₹1,888 crores and a proposed final dividend of ₹6 per share. The company reversed ₹151 crores in deferred tax due to new tax regime transition, while maintaining a strong 19.5% net profit margin. It proposed a ₹5,000 crore capital raise via QIP and appointed Aman Mehta as Managing Director effective August 1, 2025, pending shareholder approval.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this financial results affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 20 May 2025?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 20 May 2025

ZYDUSLIFE Zydus Lifesciences Limited Corporate Action ZYDUSLIFE Zydus Lifesciences Limited Financial Results SIEMENS Siemens Limited Financial Results ZYDUSLIFE Zydus Lifesciences Limited Corporate Action SRF SRF Limited Financial Results ZYDUSLIFE Zydus Lifesciences Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.